「Humanized mouse models with endogenously developed human natural killer cells for in vivo immunogenicity testing of HLA class I-edited iPSC-derived cells」の関連論文
-
Cell therapy for Parkinson's disease with induced pluripotent stem cells
-
Production and nonclinical evaluation of an autologous iPSC-derived platelet product for the iPLAT1 clinical trial
-
Evading the Immune System: Immune Modulation and Immune Matching in Cell Replacement Therapies for Parkinson’s Disease
-
Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients
-
Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome
-
Core-shell hydrogel microfiber-expanded pluripotent stem cell-derived lung progenitors applicable to lung reconstruction in vivo
-
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation
-
Automated measurement of fluorescence signals reveals a significant increase of the graft-derived neurite extension in neonates compared to aged rats
-
Possible NK cell-mediated immune responses against iPSC-derived cells in allogeneic transplantation settings
-
Platelet Transfusion Refractoriness in Single-Unit Cord Blood Transplantation For Adults: Risk Factors and Clinical Outcomes
-
Pluripotent stem cell-based therapies and their path to the clinic
-
Development of platelet replacement therapy using human induced pluripotent stem cells